Tech Company Financing Transactions
Argolyn Bioscience Funding Round
Argolyn Bioscience closed a $2 million financing round on 3/31/2009. Investors included Intersouth Partners and Quaker Partners.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Intersouth Partners (Dennis Dougherty)
Quaker Partners (Geeta Vemuri)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2530 Meridian Pkwy. 200
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Website
Email Address
Overview
Argolyn Bioscience, Inc. is a privately held biopharmaceutical company dedicated to discovering and developing novel peptide drug candidates to treat psychosis, pain, and other serious diseases and disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nixon Ellis
Chief Scientific Officer
Thomas Dix
Browse more venture capital transactions:
Prev: 3/31/2009: ideeli venture capital transaction
Next: 3/31/2009: Plastic Logic venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs